[go: up one dir, main page]

BRPI0813897A2 - USE OF A SUBSTANCE, COSMETIC OR DERMOSCOSMETIC OR NEUTRACETIC COMPOSITION, PHARMACEUTICAL COMPOSITION, COSMETIC CARE METHOD, AND NUCLEOTIDE SEQUENCE. - Google Patents

USE OF A SUBSTANCE, COSMETIC OR DERMOSCOSMETIC OR NEUTRACETIC COMPOSITION, PHARMACEUTICAL COMPOSITION, COSMETIC CARE METHOD, AND NUCLEOTIDE SEQUENCE.

Info

Publication number
BRPI0813897A2
BRPI0813897A2 BRPI0813897-4A2A BRPI0813897A BRPI0813897A2 BR PI0813897 A2 BRPI0813897 A2 BR PI0813897A2 BR PI0813897 A BRPI0813897 A BR PI0813897A BR PI0813897 A2 BRPI0813897 A2 BR PI0813897A2
Authority
BR
Brazil
Prior art keywords
cosmetic
composition
neutracetic
dermoscosmetic
substance
Prior art date
Application number
BRPI0813897-4A2A
Other languages
Portuguese (pt)
Inventor
Sabine Pain
Colette Dezutter
Valerie Andre
Corinne Reymermier
Isabelle Orly
Eric Perrier
Original Assignee
Basf Beauty Care Solutions F
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Beauty Care Solutions F filed Critical Basf Beauty Care Solutions F
Publication of BRPI0813897A2 publication Critical patent/BRPI0813897A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13—Coniferophyta (gymnosperms)
    • A61K36/14—Cupressaceae (Cypress family), e.g. juniper or cypress
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/24—Apocynaceae (Dogbane family), e.g. plumeria or periwinkle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/90—Smilacaceae (Catbrier family), e.g. greenbrier or sarsaparilla
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9755—Gymnosperms [Coniferophyta]
    • A61K8/9761—Cupressaceae [Cypress family], e.g. juniper or cypress
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9794—Liliopsida [monocotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Emergency Medicine (AREA)
  • Toxicology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
BRPI0813897-4A2A 2007-06-06 2008-06-06 USE OF A SUBSTANCE, COSMETIC OR DERMOSCOSMETIC OR NEUTRACETIC COMPOSITION, PHARMACEUTICAL COMPOSITION, COSMETIC CARE METHOD, AND NUCLEOTIDE SEQUENCE. BRPI0813897A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0755529A FR2916977A1 (en) 2007-06-06 2007-06-06 STIMULATION OF SYNTHESIS OF MCR1, MCR2 AND μ OPIOID RECEPTORS.
PCT/EP2008/057130 WO2008148892A2 (en) 2007-06-06 2008-06-06 Mc- i r, mc-2 r, and mu opioid receptors modulation

Publications (1)

Publication Number Publication Date
BRPI0813897A2 true BRPI0813897A2 (en) 2014-12-30

Family

ID=38961885

Family Applications (2)

Application Number Title Priority Date Filing Date
BRPI0813897-4A2A BRPI0813897A2 (en) 2007-06-06 2008-06-06 USE OF A SUBSTANCE, COSMETIC OR DERMOSCOSMETIC OR NEUTRACETIC COMPOSITION, PHARMACEUTICAL COMPOSITION, COSMETIC CARE METHOD, AND NUCLEOTIDE SEQUENCE.
BRPI0812575A BRPI0812575B1 (en) 2007-06-06 2008-06-06 Use of a Substance, Cosmetic or Dermo-Cosmetic or Neutracutic Composition, Pharmaceutical Composition, Cosmetic Care Method, and Nucleotide Sequence

Family Applications After (1)

Application Number Title Priority Date Filing Date
BRPI0812575A BRPI0812575B1 (en) 2007-06-06 2008-06-06 Use of a Substance, Cosmetic or Dermo-Cosmetic or Neutracutic Composition, Pharmaceutical Composition, Cosmetic Care Method, and Nucleotide Sequence

Country Status (9)

Country Link
US (2) US20100272699A1 (en)
EP (3) EP2157978A2 (en)
JP (4) JP2010529960A (en)
KR (3) KR20150030281A (en)
CN (2) CN101772349A (en)
BR (2) BRPI0813897A2 (en)
ES (1) ES2730836T3 (en)
FR (1) FR2916977A1 (en)
WO (2) WO2008148892A2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113012977A (en) * 2021-04-20 2021-06-22 国网冀北电力有限公司检修分公司 Tank-type circuit breaker staged heating device
CN113867252A (en) * 2021-10-13 2021-12-31 南京凌华微电子科技有限公司 A PLC data acquisition and processing method and device for vacuum cleaner testing

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2916977A1 (en) * 2007-06-06 2008-12-12 Engelhard Lyon Sa STIMULATION OF SYNTHESIS OF MCR1, MCR2 AND μ OPIOID RECEPTORS.
CN101999999B (en) * 2009-09-01 2012-02-01 珈侬生化科技(中国)有限公司 Method for preparing active extract of Juniperus sibirica and whitening and anti-ageing active cosmetic
CN101691596B (en) * 2009-10-15 2012-02-29 哈尔滨商业大学 Method for producing exorphins by hydrolyzing soybean protein
FR2999933B1 (en) * 2012-12-21 2020-01-31 Société des Produits Nestlé S.A. USE OF PROBIOTIC MICROORGANISMS AS A MELANIN SYNTHESIS AGENT
FR2999931A1 (en) * 2012-12-21 2014-06-27 Oreal USE OF PROBIOTIC MICROORGANISMS AS AN AGENT PROMOTING MELANIN SYNTHESIS
FR2999932B1 (en) * 2012-12-21 2020-01-31 Société des Produits Nestlé S.A. USE OF PROBIOTIC MICROORGANISMS AS A MELANIN SYNTHESIS AGENT
FR2999930A1 (en) * 2012-12-21 2014-06-27 Oreal USE OF PROBIOTIC MICROORGANISMS AS AN AGENT PROMOTING MELANIN SYNTHESIS
FR3000488B1 (en) 2012-12-27 2015-10-02 Basf Beauty Care Solutions F NOVEL DERIVATIVES OF SINAPIC ACID AND THEIR COSMETIC OR PHARMACEUTICAL USES
FR3004348A1 (en) * 2013-04-11 2014-10-17 Limousine D Applic Biolog Soc Ind USE OF CUTANEOUS CELL AUTOPHAGIC ACTIVATORS TO PROMOTE CELL AND TISSUE LONGEVITY OF THE SKIN
JP2014062136A (en) * 2014-01-17 2014-04-10 Oriza Yuka Kk Melanogenesis inhibitor
JP6687525B2 (en) * 2014-01-30 2020-04-22 ブイアイビー ブイゼットダブリュＶｉｂ Ｖｚｗ Opioid receptor binding agents and uses thereof
JP5629841B1 (en) * 2014-08-06 2014-11-26 大高酵素株式会社 Method for producing fermented cosmetic and lactic acid bacteria strain
CN106146445B (en) * 2015-04-27 2018-10-19 中国人民解放军第二军医大学 The extracting method of monomer dehydrogenation matricarin ketone and its application in sagebruss artemisia anomalas
US10093960B2 (en) 2015-07-24 2018-10-09 Molecular Devices, Llc Luminescence measurement of biological samples utilizing dual reagents
EP3436156A1 (en) 2016-03-31 2019-02-06 Gojo Industries, Inc. Antimicrobial peptide stimulating cleansing composition
CA3018866C (en) 2016-03-31 2024-03-26 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
WO2018098152A1 (en) 2016-11-23 2018-05-31 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
JP7269890B2 (en) 2017-07-12 2023-05-09 ユニリーバー・アイピー・ホールディングス・ベスローテン・ヴェンノーツハップ Lyophilized active composition and system for using said composition
IT201700089680A1 (en) * 2017-08-03 2019-02-03 Giuliani Spa SYNERGIC COMPOSITION AS A SELF-MAGIC PROMOTER / A SYNERGISTIC COMPOSITION AS A PROMOTER OF AUTOPHAGY
FR3075646B1 (en) * 2017-12-21 2019-12-20 Robertet S.A. USE OF ABSOLUTE IN COSMETICS TO DEPIGMENT SKIN
CN113402506B (en) * 2021-06-17 2023-06-16 四川大学 Intermediate, preparation method and application thereof in synthesizing vinca-bunting
CN118986781A (en) * 2024-07-31 2024-11-22 山东福瑞达生物股份有限公司 Composition for improving mitochondrial activity and application of composition in cosmetics

Family Cites Families (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR595821A (en) 1924-12-08 1925-10-09 Merck E Process for separating mixed liquids
US3522350A (en) * 1969-11-10 1970-07-28 Arthur Goldberg Process for extracting an anti-inflammatory and anti - irritant principle from yarrow and the product produced thereby
IT1120139B (en) * 1979-12-04 1986-03-19 Kibarska Totka ANTI-WRINKLE AGENT PROCEDURE TO PREPARE IT AND ANTI-WRINKLE COSMETIC PREPARATION CONTAINING THAT AGENT
FR2557452B1 (en) * 1983-12-28 1986-08-14 Roussel Uclaf NOVEL COMPOSITIONS FOR SKIN CARE CONTAINING PRIMER OIL AND RATE TISSUE TRAITS
FR2559390A1 (en) * 1984-02-10 1985-08-16 Szilasmenti Mgtsz Skin regeneration agents
FR2578422B1 (en) * 1985-03-05 1987-06-26 Cariel Leon TREATMENT COMPOSITION FOR EXTERNAL LUTEOLINE-BASED USE AND PREPARATION METHOD
LU85863A1 (en) * 1985-04-22 1986-11-05 Oreal COSMETIC COMPOSITION FOR THE TREATMENT OF HAIR, ESPECIALLY OILY HAIR, BASED ON MILLEFEUILLE EXTRACT (ACHILEA MILLEFOLIUM L)
US5057502A (en) * 1987-06-02 1991-10-15 Walsh William E Composition and topical and systemic treatments of conditions caused by heavy, oily or greasy secretions
CN1102090A (en) * 1993-10-23 1995-05-03 中国科学院大连化学物理研究所 Cosmetics prepared by using oenothera oil as raw material
US5932779A (en) * 1996-06-10 1999-08-03 Millennium Pharmaceuticals, Inc. Screening methods for compounds useful in the regulation of body weight
CN1226816A (en) * 1996-08-02 1999-08-25 普拉姆开米制品股份有限公司 Oil-in-water emulsion for use on human skin for cleansing, preserving or improving skin condition
JPH11158053A (en) * 1997-12-01 1999-06-15 Nippon Shinyaku Co Ltd Cosmetic
JPH11246336A (en) * 1998-02-27 1999-09-14 Ichimaru Pharcos Co Ltd Activated oxygen scavenger and skin beautifying cosmetic composition
WO2000018416A1 (en) * 1998-09-30 2000-04-06 Industrial Research Limited Antioxidant compositions and process for their preparation
JP3522609B2 (en) * 1999-10-14 2004-04-26 株式会社ノエビア Hyaluronic acid production promoter and skin external preparation containing the same
JP2001233725A (en) * 2000-02-23 2001-08-28 Shin Nippon Yakugyou Kk Cosmetic composition containing polyphenol compound derived from oenothera tetraptera
JP2001302440A (en) * 2000-04-17 2001-10-31 Masaaki Okubo Cosmetic
JP2001335497A (en) * 2000-05-25 2001-12-04 Kose Corp Skin care preparation and skin care preparation composition
JP2002020225A (en) * 2000-07-10 2002-01-23 Naris Cosmetics Co Ltd Humectant composition
JP4402278B2 (en) * 2000-10-27 2010-01-20 日本メナード化粧品株式会社 Whitening cosmetics
FR2817747B1 (en) * 2000-12-11 2004-12-03 Oreal USE OF AT LEAST ONE SAPOGENIN, OR A NATURAL EXTRACT CONTAINING IT, TO PREVENT THE SIGNS OF SKIN AGING
JP2002193783A (en) * 2000-12-27 2002-07-10 Kanebo Ltd Cosmetic composition
JP2002205950A (en) * 2001-01-10 2002-07-23 Ichimaru Pharcos Co Ltd Elastase activity inhibitor and cosmetic composition
FR2825273B1 (en) 2001-05-29 2006-11-24 Oreal COMPOSITION FOR THE TREATMENT OF SKIN SIGNS OF AGING
DE20112636U1 (en) * 2001-07-31 2002-01-10 Kundic Sida Pasty mass for skin care
US20030110518A1 (en) * 2001-09-28 2003-06-12 Houseknecht Karen L. Melanocortin-5 receptor sequences and uses thereof
JP2003113066A (en) * 2001-10-01 2003-04-18 Ai Corporation:Kk Cosmetics
JP2003192568A (en) * 2001-12-27 2003-07-09 Nonogawa Shoji Kk Fragrant cosmetic composition
JP2003212770A (en) * 2002-01-22 2003-07-30 Ichimaru Pharcos Co Ltd Maillard reaction inhibitor
US20030186249A1 (en) * 2002-04-01 2003-10-02 Zairen Sun Human TARPP genes and polypeptides
JP3908126B2 (en) * 2002-08-30 2007-04-25 株式会社ナリス化粧品 Epidermal keratinization normalizing agent and skin external preparation containing the same
JP3544541B2 (en) * 2002-10-04 2004-07-21 株式会社アイデアる Compost cutting stirrer
JP2004137233A (en) * 2002-10-21 2004-05-13 Kose Corp Antiaging agent and external preparation for skin using the same
FR2847267B1 (en) 2002-11-19 2006-07-28 Coletica METHOD FOR TESTING THE ACTIVITY OF A POTENTIALLY ACTIVE SUBSTANCE FOR INHIBITING THE ENZYMATIC ACTIVITY OF A2 PHOSPHOLIPASE
KR100513082B1 (en) * 2002-11-27 2005-09-07 나드리화장품주식회사 Cosmetic composition containing ceramide liposome with phyto complex extract and ceramide
JP2004196669A (en) * 2002-12-16 2004-07-15 Kose Corp Melanocyte proliferation inhibitor and skin care preparation for external use comprising the same
EP1617845A4 (en) * 2003-04-28 2006-09-20 3M Innovative Properties Co Compositions and methods for induction of opioid receptors
TW200512007A (en) * 2003-05-30 2005-04-01 Fullerene Internat Corp Cosmetic compositions containing fullerene clusters
FR2855968B1 (en) 2003-06-13 2012-11-30 Coletica STIMULATION OF THE SYNTHESIS AND ACTIVITY OF A LYSYL OXIDASE-LIKE LOXL ISOFORM TO STIMULATE THE FORMATION OF ELASTIC FIBERS
JP2005008539A (en) * 2003-06-17 2005-01-13 Fancl Corp Matrix metalloproteinase inhibitor
US20050036974A1 (en) 2003-07-17 2005-02-17 L'oreal Beta-endorphin activity in cosmetics and dermatology
FR2857874A1 (en) 2003-07-21 2005-01-28 Courtage Et De Diffusion Codif Use of beta-endorphin, or agents that stimulate its production, for pharmaceutical or cosmetic modification of keratinocyte differentiation
EP1689494B1 (en) * 2003-10-14 2008-12-03 Showa Denko K.K. Agent for skin external use containing salt of ascorbic acid derivative, method for stabilizing the agent for skin external use
US20060233739A1 (en) * 2003-11-24 2006-10-19 Thornfeldt Carl R Treatment of mucocutaneous disorders through reversing chronic imflammation and barrier disruption
EP1543825A1 (en) * 2003-12-15 2005-06-22 Kuraray Co., Ltd. Skin lightening preparation comprising n-butyl resorcinol and a flavonoid
ES2235642B2 (en) * 2003-12-18 2006-03-01 Gat Formulation Gmbh CONTINUOUS MULTI-MICROENCAPSULATION PROCESS FOR THE IMPROVEMENT OF STABILITY AND STORAGE OF BIOLOGICALLY ACTIVE INGREDIENTS.
BG65694B1 (en) * 2003-12-31 2009-07-31 НАЙДЕНОВ Владимир MEANS FOR TREATMENT OF DERMATOSES
JP4569312B2 (en) * 2004-02-25 2010-10-27 大正製薬株式会社 Whitening agent
FR2867476B1 (en) * 2004-03-11 2006-05-26 Michel Prost GENKWANINE AND SAKURANETINE DERIVATIVES, COSMETIC AND THERAPEUTIC USE, AND PREPARATION METHOD
DE102004049062A1 (en) * 2004-03-30 2005-10-13 bitop Aktiengesellschaft für biotechnische Optimierung Topical preparation for application on the skin containing natural oil of the evening primrose (Oenothera biennis) (= Oleum Oenothera) and osmolytes from extremophilic microorganisms
US20050220744A1 (en) * 2004-03-31 2005-10-06 Showa Denko K.K. Polysaccharide/functional compound complex
JP2005314286A (en) * 2004-04-28 2005-11-10 Zenzaburo Hara Bleaching cosmetic
JP2006001837A (en) * 2004-06-15 2006-01-05 Nonogawa Shoji Kk Opioid receptor damage inhibitor
DE102004038728A1 (en) * 2004-08-10 2006-03-02 Merck Patent Gmbh Flavonoid complexes
JP4387903B2 (en) * 2004-09-09 2009-12-24 株式会社東洋新薬 Fermented material obtained from papaya
JP2006076927A (en) * 2004-09-09 2006-03-23 Toyo Shinyaku:Kk Fermented material obtained from mango
JP2006117612A (en) * 2004-10-25 2006-05-11 Ichimaru Pharcos Co Ltd Active oxygen eliminating agent
JP2008520588A (en) * 2004-11-18 2008-06-19 ビオファーマコペ デジン アンテルナショナル インク． Plant extract and its dermatological usage
JP2006176414A (en) * 2004-12-21 2006-07-06 Noevir Co Ltd External preparation for skin
JP2006249000A (en) * 2005-03-11 2006-09-21 Aging Kenkyusho:Kk Bleaching cosmetic and bleaching cosmetic set
JP2006347995A (en) * 2005-06-20 2006-12-28 Yukihiro Hirose Composition for makeup
FI118117B (en) * 2005-08-12 2007-07-13 Lumene Oy Cosmetic product for the treatment of the scalp
WO2007030666A2 (en) * 2005-09-07 2007-03-15 Herbal Intervention Corporation Medicated skin care preparation for promoting wound healing
EP1926490A2 (en) * 2005-09-23 2008-06-04 DSMIP Assets B.V. Use of opioid receptor antagonists
FR2893252B1 (en) 2005-11-17 2008-02-15 Engelhard Lyon Sa VEGETABLE EXTRACTS STIMULATING HAS2
IL179539A (en) * 2006-11-23 2010-11-30 Redent Nova Ltd Dental irrigator
JP4902747B2 (en) * 2007-04-02 2012-03-21 ドンウォン カン Contact lens storage case
FR2916977A1 (en) * 2007-06-06 2008-12-12 Engelhard Lyon Sa STIMULATION OF SYNTHESIS OF MCR1, MCR2 AND μ OPIOID RECEPTORS.

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113012977A (en) * 2021-04-20 2021-06-22 国网冀北电力有限公司检修分公司 Tank-type circuit breaker staged heating device
CN113867252A (en) * 2021-10-13 2021-12-31 南京凌华微电子科技有限公司 A PLC data acquisition and processing method and device for vacuum cleaner testing

Also Published As

Publication number Publication date
WO2008148892A3 (en) 2009-03-12
FR2916977A1 (en) 2008-12-12
US20100209407A1 (en) 2010-08-19
EP2157966B1 (en) 2019-03-13
BRPI0812575B1 (en) 2017-04-11
EP2157978A2 (en) 2010-03-03
WO2008148891A3 (en) 2009-03-19
JP2010529960A (en) 2010-09-02
CN101711152B (en) 2013-09-11
WO2008148892A2 (en) 2008-12-11
KR101661769B1 (en) 2016-10-05
JP2010529092A (en) 2010-08-26
BRPI0812575A2 (en) 2014-09-30
JP6215364B2 (en) 2017-10-18
JP2016128438A (en) 2016-07-14
US20100272699A1 (en) 2010-10-28
JP2014024860A (en) 2014-02-06
ES2730836T3 (en) 2019-11-12
JP5686597B2 (en) 2015-03-18
CN101711152A (en) 2010-05-19
KR20100040836A (en) 2010-04-21
EP2574332A1 (en) 2013-04-03
CN101772349A (en) 2010-07-07
KR20150030281A (en) 2015-03-19
EP2157966A2 (en) 2010-03-03
WO2008148891A2 (en) 2008-12-11
KR20100029818A (en) 2010-03-17

Similar Documents

Publication Publication Date Title
BRPI0813897A2 (en) USE OF A SUBSTANCE, COSMETIC OR DERMOSCOSMETIC OR NEUTRACETIC COMPOSITION, PHARMACEUTICAL COMPOSITION, COSMETIC CARE METHOD, AND NUCLEOTIDE SEQUENCE.
BRPI0820568A2 (en) Compound, pharmaceutical composition, use of a compound or pharmaceutical composition, and method of treating a human or animal
BRPI0912717A2 (en) PHARMACEUTICAL COMPOSITION, AND, USE OF 5-AZACYTIDINE
BRPI0821115A2 (en) Aminotriazole-derived compound, drug, pharmaceutical composition and use of compound
BRPI0806531A2 (en) COMPOUND, PHARMACEUTICAL COMPOSITION, THERAPEUTIC AGENT, AND USE OF THE COMPOUND.
BRPI0819299A2 (en) USE OF COMPOSITION, AND, COMPOSITION CONTAINING PROTEIN
BRPI0917001A2 (en) compound, pharmaceutical composition, and use of a compound or pharmaceutical composition
BRPI0820899A2 (en) COSMETIC FORMULATION, AND, USE OF COMPOSITION
BRPI0815709A2 (en) composition, pharmaceutical composition, and use of a compound.
BRPI0917315A2 (en) antibody, pharmaceutical composition, and use of a pharmaceutical composition
FR2961814B1 (en) NOVEL SIRTUIN 6 ACTIVATOR PEPTIDES AND COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING SAME.
BRPI0816350A2 (en) ORAL COMPOSITIONS, PRODUCTS AND METHODS OF USE
BRPI0814335A2 (en) USE OF A NANODISPERSION, AND COSMETIC FINAL FORMULATION
BRPI0924177A2 (en) Polypeptides, their method of preparation, their composition, nucleotide sequence and use
BRPI0910557A2 (en) paclitaxel pharmaceutical compositions, paclitaxel analogs or paclitaxel conjugates and related methods of preparation and use.
FR2915199B1 (en) TRIAZOLOPYRIDINE-CARBOXAMIDE AND TRIAZOLOPYRIMIDINE-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE.
BRPI1015327A2 (en) "microcapsule, chemical composition, use of microcapsules, use of a chemical composition, and, article."
BRPI0918789A2 (en) beta-glucosidase variants having improved activity, and use thereof
BRPI0917661A2 (en) product containing macitentan, pharmaceutical composition containing it and use of macitentan
BRPI0915552A2 (en) cyclosporine derivatives, their use and pharmaceutical composition
BRPI0815768A2 (en) USE OF UV ABSORBENTS, AND, COSMETIC COMPOSITION.
BRPI0607198A2 (en) composition, use of composition diseases treatment method, and pharmaceutical packaging
BRPI0907228A2 (en) Thienopyridazine compounds, their preparations, pharmaceutical compositions and uses
BRPI0909296A2 (en) use of at least one active ingredient, and, cosmetic, pharmaceutical and / or dermatological compositions
BRPI0720323A2 (en) compound, method of treatment, pharmaceutical composition and use of the compound

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL